PDSB icon

PDS Biotechnology
PDSB

Overview Fund Activity

51 hedge funds and large institutions have $148M invested in PDS Biotechnology in 2016 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 23 increasing their positions, 8 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
51
Holders Change
-2
Holders Change %
-3.77%
% of All Funds
1.36%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.08%
New
4
Increased
23
Reduced
8
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$6.96M
2
ACP
2
Acuta Capital Partners
California
$7.32M
3
Franklin Resources
3
Franklin Resources
California
$26M
4
Geode Capital Management
4
Geode Capital Management
Massachusetts
$1.68M
5
OM
5
Opaleye Management
Massachusetts
$2.92M

Top Sellers

1
NC
1
Nexthera Capital
New York
$0
2
JHIU
2
Janus Henderson Investors US
Colorado
$23.7M
3
Goldman Sachs
3
Goldman Sachs
New York
$0
4
Asset Management One
4
Asset Management One
Japan
$2.31M
5
RJA
5
Raymond James & Associates
Florida
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
TCIM
51
TIAA CREF Investment Management
New York
$471 -$19 -93 -4%
NC
52
Nexthera Capital
New York
– -$1.37M -6,792 Closed
Goldman Sachs
53
Goldman Sachs
New York
– -$453K -2,239 Closed
RJA
54
Raymond James & Associates
Florida
– -$233K -1,154 Closed
ARTA
55
A.R.T. Advisors
New York
– -$206K -1,020 Closed
Citigroup
56
Citigroup
New York
– -$16K -81 Closed
BJ
57
BlackRock Japan
Japan
– -$8K -38 Closed
1 2
3